Patents by Inventor Chetan Goudar

Chetan Goudar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220356502
    Abstract: The invention provides methods and materials for culturing mammalian cells and harvesting recombinant protein.
    Type: Application
    Filed: May 17, 2022
    Publication date: November 10, 2022
    Applicant: AMGEN INC.
    Inventors: Chetan GOUDAR, Sean COLE, Nicole SABO, Henry LIN, Jonathan LULL, Tharmala THARMALINGAM
  • Patent number: 11427848
    Abstract: The invention provides methods and materials for culturing mammalian cells and harvesting recombinant protein.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: August 30, 2022
    Assignee: AMGEN INC.
    Inventors: Chetan Goudar, Sean Cole, Nicole Sabo, Henry Lin, Jonathan Lull, Tharmala Tharmalingam
  • Patent number: 11384378
    Abstract: The invention provides methods and materials for culturing mammalian cells and harvesting recombinant protein.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: July 12, 2022
    Assignee: AMGEN INC.
    Inventors: Chetan Goudar, Sean Cole, Nicole Le, Henry Lin, Jonathan Lull, Tharmala Tharmalingam
  • Publication number: 20220136025
    Abstract: The invention provides methods and materials for culturing mammalian cells and harvesting recombinant protein.
    Type: Application
    Filed: November 30, 2021
    Publication date: May 5, 2022
    Applicant: AMGEN INC.
    Inventors: Chetan GOUDAR, Sean COLE, Nicole SABO, Henry LIN, Jonathan LULL, Tharmala THARMALINGAM
  • Publication number: 20210163592
    Abstract: The present invention provides a continuous upstream manufacturing process for the production of bispecific antibody products, which comprise at least two binding domains. The process comprises at least the steps of (i) providing in a perfusion bioreactor at least one mammalian cell culture, which is capable of expressing the bispecific antibody product, (ii) growing the mammalian cell culture at a first perfusion rate until a set point viable cell density is reached, and (iii) maintaining perfusion culture at a second perfusion rate, wherein the bispecific antibody product concentration in the bioreactor is kept below a threshold value. The bispecific antibody product is then subject to subsequent downstream processing. Moreover, the invention provides a bispecific antibody product produced by the continuous upstream manufacturing process.
    Type: Application
    Filed: December 11, 2018
    Publication date: June 3, 2021
    Inventors: Chetan Goudar, Rohini Deshpande, Natalia Gomez, Hedieh Barkhordarian, Yan Wang
  • Publication number: 20170114381
    Abstract: The invention provides methods and materials for culturing mammalian cells and harvesting recombinant protein.
    Type: Application
    Filed: June 4, 2015
    Publication date: April 27, 2017
    Applicant: AMGEN INC.
    Inventors: Chetan GOUDAR, Sean COLE, Nicole LE, Henry LIN, Jonathan LULL, Tharmala THARMALINGAM
  • Publication number: 20120088679
    Abstract: The present invention is directed to a method of monitoring the physiological state of a cell cultivation. Several parameters such as cell viability, growth, metabolic profile, and productivity may be monitored to establish a metabolic fingerprint or metabolomic profile of a cell culture.
    Type: Application
    Filed: March 10, 2010
    Publication date: April 12, 2012
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Chetan Goudar, Maria Klapa